• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number TRM-310
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 01/20/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Reason for reoperation: capsular contracture baker grade unknown.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.
 
Event or Problem Description
Healthcare professional reported right side capsular contracture, baker grade unknown.Device remains implanted.
 
Event or Problem Description
Healthcare professional additionally reported capsular contracture, baker grade iii.Device has been explanted.
 
Additional Manufacturer Narrative
Device evaluation: analysis of the returned device identified: creases fold, deformation device, black particles in the shell and weigh to the spec.Bubbles in the gel observed after the autoclave cycle.Based on the device analysis the final assessment is: no issues found related with the manufacturing process.
 
Event or Problem Description
Healthcare professional additionally reported and confirmed capsular contracture, baker grade iii.Device has been explanted.
 
Additional Manufacturer Narrative
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to (b)(4) has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.A review of the device history record has been completed.No deviations or non-conformities noted.Additional, changed, and/or corrected data: b.5., d.7., e.3., d.10., h.3., h.6.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
MDR Report Key9688442
Report Number9617229-2020-03022
Device Sequence Number11618691
Product Code FTR
UDI-Device Identifier10888628008083
UDI-Public10888628008083
Combination Product (Y/N)N
Initial Reporter StateCA
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2020
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/30/2020
Device Model NumberTRM-310
Device Catalogue NumberTRM-310
Device Lot Number2784748
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/26/2020
Initial Date Received by Manufacturer 02/05/2020
Supplement Date Received by Manufacturer03/12/2020
05/15/2020
Initial Report FDA Received Date02/10/2020
Supplement Report FDA Received Date04/23/2020
06/14/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age43 YR
-
-